ENOVIS CORPORATION COMMON STOCK

Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference

05 Jan 2023 12:10:18 By Nasdaq GlobeNewswire

Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle

01 Dec 2022 06:00:01 By Nasdaq GlobeNewswire

Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting

10 Nov 2022 07:30:00 By Nasdaq GlobeNewswire

Enovis Announces Third Quarter 2022 Results

02 Nov 2022 03:00:00 By Nasdaq GlobeNewswire

Enovis to Participate in Investor Conferences in November

28 Oct 2022 12:57:58 By Nasdaq GlobeNewswire

Enovis to Host Third Quarter 2022 Conference Call on November 2nd

13 Oct 2022 06:30:00 By Nasdaq GlobeNewswire

Enovis to Showcase New 510(k) Cleared Foot & Ankle Products at the AOFAS Annual Meeting

08 Sep 2022 06:30:00 By Nasdaq GlobeNewswire

Enovis to Participate in Investor Conferences in September

25 Aug 2022 13:01:00 By Nasdaq GlobeNewswire

Enovis Announces Second Quarter 2022 Results

04 Aug 2022 03:00:01 By Nasdaq GlobeNewswire

Enovis to Host Second Quarter 2022 Conference Call on August 4th

12 Jul 2022 13:01:00 By Nasdaq GlobeNewswire

Enovis Completes Acquisition of Insight Medical Systems

06 Jul 2022 05:00:02 By Nasdaq GlobeNewswire

Enovis Announces Chief Financial Officer Transition Plan

30 Jun 2022 05:00:01 By Nasdaq GlobeNewswire

Enovis to Participate in the Goldman Sachs Global Healthcare Conference

06 Jun 2022 13:05:00 By Nasdaq GlobeNewswire

Enovis Announces First Quarter 2022 Adjusted Stand Alone Results

10 May 2022 04:11:29 By Nasdaq GlobeNewswire

Enovis Schedules First Quarter 2022 Earnings Release and Conference Call

14 Apr 2022 10:23:19 By Nasdaq GlobeNewswire